Summary Verisante Technology Inc (Verisante), formerly T-Ray Science, Inc., carries out the development and commercialization of products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for lung, colon and cervical cancer detection. Verisante MSI Camera is a multispectral imaging camera used in the detection of oral and skin cancer. The cancer detection technology helps the company to develop and offer wide range of compact and non-invasive cancer detection devices. The company is ISO 13485:2003 certified as a medical device manufacturer. Verisante is headquartered in Richmond, British Columbia, Canada. Verisante Technology Inc (VRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a... Research Beam Model: Research Beam Product ID: 2136271 250 USD New
Verisante Technology Inc (VRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Verisante Technology Inc (VRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : September   2017
  • Pages : 18
  • Publisher : GlobalData
 
 
 
Summary

Verisante Technology Inc (Verisante), formerly T-Ray Science, Inc., carries out the development and commercialization of products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for lung, colon and cervical cancer detection. Verisante MSI Camera is a multispectral imaging camera used in the detection of oral and skin cancer. The cancer detection technology helps the company to develop and offer wide range of compact and non-invasive cancer detection devices. The company is ISO 13485:2003 certified as a medical device manufacturer. Verisante is headquartered in Richmond, British Columbia, Canada.

Verisante Technology Inc (VRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Verisante Technology Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Verisante Technology Inc, Medical Devices Deals, 2011 to YTD 2017 9
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Verisante to Enter into Licensing Agreement to Develop Core Device for Lung Cancer 11
Equity Offering 12
Verisante Technology Raises USD0.08 Million in Private Placement of Shares 12
Verisante Raises USD0.27 Million in Private Placement of Shares 13
Verisante Technology Completes Private Placement Of Units For US$0.4 Million 14
Verisante Technology Inc - Key Competitors 15
Verisante Technology Inc - Key Employees 16
Verisante Technology Inc - Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18
List of Tables
Verisante Technology Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Verisante Technology Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Verisante Technology Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Verisante Technology Inc, Medical Devices Deals, 2011 to YTD 2017 9
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Verisante to Enter into Licensing Agreement to Develop Core Device for Lung Cancer 11
Verisante Technology Raises USD0.08 Million in Private Placement of Shares 12
Verisante Raises USD0.27 Million in Private Placement of Shares 13
Verisante Technology Completes Private Placement Of Units For US$0.4 Million 14
Verisante Technology Inc, Key Competitors 15
Verisante Technology Inc, Key Employees 16List of Figures
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Verisante Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Verisante Technology Inc, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter